Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium

Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium

Conditions: Retinopathy; Retinal Vein Occlusion; Diabetic Retinopathy; Macular Degeneration
Interventions: Combination Product: Fluorescein sodium and Zeiss FF450 fundus camera; Combination Product: MB-102 and Zeiss FF450 fundus camera; Combination Product: Fluorescein sodium and commercially available optical angiography imaging system; Combination Product: MB-102 and commercially available optical angiography imaging system
Sponsors: MediBeacon
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 2, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments